ResearchMoz

Patent Analysis Market Research Reports & Industry Analysis

Patent Analysis Market Research Reports & Industry Analysis Patent Analysis

Browse reports in Patent Analysis

Displaying 1 to 30 (of 635 records)
Pages: « Last  1 2 3 4 5 6 7 8 9 10   Next »
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May 2013   |   By - GenericsWeb
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players....
$1200
Doripenem - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May 2013   |   By - GenericsWeb
Doripenem - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This...
$1200
Abacavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Abacavir Abacavir indications: In combination with other...
$1200
Acitretin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Acitretin Acitretin indications: Psoriasis; Congenital...
$1200
Adalimumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Adalimumab Adalimumab indications: Rheumatoid arthritis;...
$1200
Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Adefovir Adefovir indications: Treatment of chronic hepatitis B...
$1200
Alendronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alendronic Acid Alendronic Acid indications:...
$1200
Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alendronic Acid (Ext) Alendronic Acid (Ext) indications:...
$1200
Alverine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alverine Alverine indications: Adjunct in gastro-intestinal...
$1200
Amphotericin B - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Amphotericin B A mphotericin B indications: Potentially...
$1200
Aripiprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Aripiprazole Aripiprazole indications: Schizophrenia...
$1200
Armodafinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Armodafinil Armodafinil indications: Excessive sleepiness...
$1200
Atovaquone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Atovaquone Atovaquone indications: Pneumocystic carinii...
$1200
Azelastine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Azelastine Azelastine indications: Treatment of allergic...
$1200
Barnidipine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Barnidipine Barnidipine indications: Hypertension...
$1200
Bevacizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Bevacizumab Bevacizumab indications: In combination with 5-Fluorouracil...
$1200
Bortezomib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Bortezomib Bortezomib indications: Treatment of patients...
$1200
Brimonidine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brimonidine Brimonidine indications: Open-angle glaucoma,...
$1200
Brinzolamide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brinzolamide Brinzolamide indications: Ocular hypertension;...
$1200
Budesonide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Budesonide Budesonide indications: Treatment of hay-fever,...
$1200
Caspofungin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Caspofungin Caspofungin indications: Empirical therapy...
$1200
Celecoxib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Celecoxib Celecoxib indications: Familial adenomatous...
$1200
Cetirizine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetirizine Cetirizine indications: Seasonal & perennial...
$1200
Cetuximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetuximab Cetuximab indications: Colorectal cancer;...
$1200
Ciprofloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciprofloxacin Ciprofloxacin indications: Urinary tract infections,...
$1200
Ciclosporin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciclosporin Ciclosporin indications: Immunosuppressant;...
$1200
Darbepoetin alfa - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Darbepoetin alfa Darbepoetin alfa indications: Anaemia...
$1200
Desvenlafaxine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Desvenlafaxine Desvenlafaxine indications: Depression Desvenlafaxine...
$1200
Doxercalciferol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Doxercalciferol Doxercalciferol indications: Secondary hyperparathyroidism...
$1200
Drospirenone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Drospirenone Drospirenone indications: Prevention of pregnancy in women....
$1200
 
Displaying 1 to 30 (of 635 records)
Pages: « Last  1 2 3 4 5 6 7 8 9 10   Next »